SLN
Silence Therapeutics Plc - ADR

371
Loading...
Loading...
Silence Therapeutics Plc engages in the discovery, delivery, and development of ribonucleic acid (RNA) therapeutics. It also develops medicines by harnessing the body's natural mechanism of RNA interference within its cells. The company was founded on November 18, 1994 and is headquartered in London, the United Kingdom.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
116

Frequently Asked Questions

What is Market Cap of Silence Therapeutics Plc - ADR?
What is the 52-week high for Silence Therapeutics Plc - ADR?
What is the 52-week low for Silence Therapeutics Plc - ADR?
What is Silence Therapeutics Plc - ADR stock price today?
What was Silence Therapeutics Plc - ADR stock price yesterday?
What is the PE ratio of Silence Therapeutics Plc - ADR?
What is the Price-to-Book ratio of Silence Therapeutics Plc - ADR?
What is the 50-day moving average of Silence Therapeutics Plc - ADR?
How many employess does Silence Therapeutics Plc - ADR has?

Latest SLN News

View

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.